💊FDA Approvals | Notable Recent Oncology Drugs
🔹#Atezolizumab + chemo— Stage III dMMR colon cancer
🔹#Tucatinib combo— HER2+ breast cancer
🔹#Pirtobrutinib— BTK inhibitor for CLL/SLL
🔹#Belzutifan + #Lenvatinib— advanced ccRCC

🔎Discover bioactive molecules for your research: https://ow.ly/2s0R50ZWcts

The FDA has approved Pfizer’s #TUKYSA (#tucatinib) + #trastuzumab + #pertuzumab for adults with unresectable locally advanced or metastatic HER2-positive breast cancer following induction treatment.
🧪Tucatinib for research use from MedChemExpress: https://www.medchemexpress.com/Irbinitinib.html